●
DMAC
DiaMedica Therapeutics Inc.
$750K
Single buy
Discretionary Insider Activity
Date:
04/10/2023
Insiders:
Wambeke David J., Chief Business Officer
Prior trend:
8 months of no clear discretionary insider activity

Summary

A $750K single buy for DiaMedica Therapeutics Inc. (DMAC) on 04/10/2023 after 8 months of no clear discretionary insider activity trend.

Reports

Action Amount Date Insider Role(s) SEC Filing No
● Buy $750K 04/11/2023 Wambeke David J. Chief Business Officer 0001235802-23-000040

Transactions

Action Amount Date Insider Security Type SEC Code
● Buy $750K 04/10/2023 Wambeke David J. Voting Common Shares, no par value per share Discretionary Purchase
● N/A – 04/10/2023 Wambeke David J. Stock Option (right to buy) Non-discretionary Grant/Award

Stats

Prior max multiple:
3.1
Prior median multiple:
5.6

Metadata

Signal ID:
YOZwZNwJzBEAJllZ
Detected on:
04/22/2023